NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002205

Registered date:15/09/2009

Investigation about treatment of midnight hypertension in diabetes

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedhypertension in diabetes
Date of first enrollment2009/09/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)olmesartan 20 mg +amlodipine 5mg once daily olmesartan 20 mg + azelnidipine 16 mg once daily candesartan 8 mg or varsartan 80 mg + amlodipine 5mg once daily candesartan 8 mg or varsartan 80 mg + azelnidipine 16 mg once daily

Outcome(s)

Primary Outcomecomparison of the anti-hypertensive effect through the 24 hrs
Secondary Outcomechange in urinary albumin excretion ratio

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum79years-old
GenderMale and Female
Include criteria
Exclude criteria1) drug allergy to ARB or Ca antagonist 2) pregnant women or possible pregnant women 3) using anti-fugal drug or HIV protease inhibitor 4) bilateral renal artery stenosis or unilateral renal artery stenosis of remnant kidny

Related Information

Contact

public contact
Name Kazuhiko sakaguchi
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe Japan
Telephone 078-382-5861
E-mail kzhkskgc@med.kobe-u.ac.jp
Affiliation Department od Internal Medicine, Kobe University Graduate School of Medicine Division of diabetes, metabolism and Endocrinology
scientific contact
Name Kazuhiko sakaguchi
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe Japan
Telephone 078-382-5861
E-mail kzhkskgc@med.kobe-u.ac.jp
Affiliation Department od Internal Medicine, Kobe University Graduate School of Medicine Division of diabetes, metabolism and Endocrinology